Literature DB >> 2153493

A study of patients with alcoholic liver disease by 31P nuclear magnetic resonance spectroscopy.

P W Angus1, R M Dixon, B Rajagopalan, N G Ryley, K J Simpson, T J Peters, D P Jewell, G K Radda.   

Abstract

1. Patients with a history of alcohol abuse were studied by 31P n.m.r. spectroscopy of the liver in vivo, and the results were related to the pattern of disease assessed by standard biochemical and histological techniques. 2. The ratios of metabolites measured from the 31P n.m.r. spectra were abnormal in patients with alcoholic hepatitis but not in those with fatty change or cirrhosis in the absence of hepatitis. In particular, the levels of phosphomonoesters were raised, with respect either to Pi, or to adenosine 5'-triphosphate. The level of phosphomonoesters showed a significant positive correlation with the severity of alcoholic hepatitis, assessed by histology. 3. The ratio of Pi to adenosine 5'-triphosphate was used as a measure of the energy status of the hepatocytes, and was unchanged between patients and controls.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153493     DOI: 10.1042/cs0780033

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  9 in total

1.  Etiology and functional status of liver cirrhosis by 31P MR spectroscopy.

Authors:  Monika Dezortova; Pavel Taimr; Antonin Skoch; Julius Spicak; Milan Hajek
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

2.  Progress in non-invasive detection of liver fibrosis.

Authors:  Chengxi Li; Rentao Li; Wei Zhang
Journal:  Cancer Biol Med       Date:  2018-05       Impact factor: 4.248

3.  Metabolic profiling of the rat liver after chronic ingestion of alpha-naphthylisothiocyanate using in vivo and ex vivo magnetic resonance spectroscopy.

Authors:  Bhavana S Solanky; Gina J Sanchez-Canon; Jeremy F L Cobbold; Simon D Taylor-Robinson; Jimmy D Bell; Cheryl L Scudamore; Eleanor Ross; Julie C Holder; Po-Wah So; I Jane Cox
Journal:  Toxicol Sci       Date:  2012-01-18       Impact factor: 4.849

4.  Development of hypoxemia in alcoholic liver disease.

Authors:  Shigeo Maruyama; Chisato Hirayama; Kazunori Maeda; Satoru Yamamoto; Masaharu Koda; Akihide Udagawa; Masayuki Inoue; Kensuke Umeki
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

5.  In vivo, high-field, 3-Tesla 1H MR spectroscopic assessment of liver fibrosis in HCV-correlated chronic liver disease.

Authors:  A Orlacchio; F Bolacchi; M Angelico; A Mancini; V Cozzolino; M Cadioli; G Simonetti
Journal:  Radiol Med       Date:  2008-04-02       Impact factor: 3.469

6.  Absolute quantification of human liver metabolite concentrations by localized in vivo 31P NMR spectroscopy in diffuse liver disease.

Authors:  Bengt Norén; Peter Lundberg; Marcus Ressner; Staffan Wirell; Sven Almer; Orjan Smedby
Journal:  Eur Radiol       Date:  2004-09-03       Impact factor: 5.315

7.  Phosphorus-31 nuclear magnetic resonance in vivo spectroscopy of human liver during hepatitis A virus infection.

Authors:  Y Yamane; M Umeda; T O'uchi; T Mitsushima; K Nakata; S Nagataki
Journal:  Dig Dis Sci       Date:  1994-01       Impact factor: 3.199

8.  In vivo and in vitro hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy in chronic ductopenic rejection of human liver allografts.

Authors:  S D Taylor-Robinson; J Sargentoni; J D Bell; E L Thomas; C D Marcus; K K Changani; N Saeed; H J Hodgson; B R Davidson; A K Burroughs; K Rolles; C S Foster; I J Cox
Journal:  Gut       Date:  1998-05       Impact factor: 23.059

9.  Altered phosphorylation status, phospholipid metabolism and gluconeogenesis in the host liver of rats with prostate cancer: a 31P magnetic resonance spectroscopy study.

Authors:  P C Dagnelie; J D Bell; S C Williams; T E Bates; P D Abel; C S Foster
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.